Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 7
1996 4
1997 4
1998 2
1999 1
2000 2
2001 3
2002 5
2003 4
2004 8
2005 9
2006 5
2007 9
2008 7
2009 10
2010 6
2011 7
2012 12
2013 9
2014 10
2015 14
2016 10
2017 9
2018 13
2019 6
2020 9
2021 8
2022 9
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement.
Boursier J, Anty R, Carette C, Cariou B, Castera L, Caussy C, Fontaine H, Garioud A, Gourdy P, Guerci B, Guillaume M, Michot N, Minello A, Ouizeman DJ, Serfaty L, Bonnet F, Vergès B, Petit JM; AFEF and SFD. Boursier J, et al. Among authors: serfaty l. Diabetes Metab. 2021 Sep;47(5):101272. doi: 10.1016/j.diabet.2021.101272. Epub 2021 Aug 4. Diabetes Metab. 2021. PMID: 34363981 Review.
Reply.
Amadou C, Nabi O, Serfaty L, Lacombe K, Boursier J, Mathurin P, Ribet C, de Ledinghen V, Zins M, Charles MA. Amadou C, et al. Among authors: serfaty l. Hepatology. 2023 Feb 1;77(2):E18. doi: 10.1002/hep.32649. Epub 2022 Jul 3. Hepatology. 2023. PMID: 35781825 No abstract available.
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Ratziu V, Corey KE, Friedman SL, Abdelmalek MF, Harrison SA, Sanyal AJ, Lavine JE, Mathurin P, Charlton MR, Goodman ZD, Chalasani NP, Kowdley KV, George J, Lindor K. Younossi ZM, et al. Among authors: serfaty l. Hepatology. 2018 Jul;68(1):349-360. doi: 10.1002/hep.29721. Hepatology. 2018. PMID: 29222917 Free PMC article.
[Pharmacological treatment of NASH].
Serfaty L. Serfaty L. Presse Med. 2019 Dec;48(12):1489-1495. doi: 10.1016/j.lpm.2019.09.015. Epub 2019 Nov 19. Presse Med. 2019. PMID: 31757735 Review. French.
[Hepatitis C].
Giral P, Serfaty L, Loria A, Poupon R. Giral P, et al. Among authors: serfaty l. Rev Med Interne. 1994;15(7):487-93. doi: 10.1016/s0248-8663(05)81475-4. Rev Med Interne. 1994. PMID: 7938962 Review. French.
Ursodeoxycholic acid in chronic hepatitis C.
Poupon R, Serfaty L. Poupon R, et al. Among authors: serfaty l. Gut. 2007 Dec;56(12):1652-3. doi: 10.1136/gut.2007.130484. Gut. 2007. PMID: 17998321 Free PMC article. Review.
185 results